Global Poxviridae Infections Drug Market Analysis 2013-2018 and Forecast 2019-2024

Table of Contents

1 Industry Overview

• 1.1 Poxviridae Infections Drug Industry
  • 1.1.1 Overview
  • 1.1.2 Development of Poxviridae Infections Drug
• 1.2 Market Segment
  • 1.2.1 Upstream
  • 1.2.2 Downstream
• 1.3 Cost Analysis

2 Industry Environment (PEST Analysis)

• 2.1 Policy
• 2.2 Economics
• 2.3 Sociology
• 2.4 Technology

3 Poxviridae Infections Drug Market by Type

• 3.1 By Type
  • 3.1.1 CJ-40011
  • 3.1.2 24a
  • 3.1.3 BA-368
  • 3.1.4 Others
• 3.2 Market Size
• 3.3 Market Forecast

4 Major Companies List

4.Poxviridae Infections Drug Bavarian Nordic A/S (Company Profile, Sales Data etc.)

• 4.2 BioFactura, Inc. (Company Profile, Sales Data etc.)
• 4.3 CEL-SCI Corporation (Company Profile, Sales Data etc.)
• 4.4 Chimerix, Inc. (Company Profile, Sales Data etc.)
• 4.5 China Biologic Products, Inc. (Company Profile, Sales Data etc.)
• 4.6 CJ HealthCare Corp. (Company Profile, Sales Data etc.)
• 4.7 EpiVax, Inc. (Company Profile, Sales Data etc.)
• 4.8 N & N Pharmaceuticals Inc. (Company Profile, Sales Data etc.)
• 4.9 SIGA Technologies, Inc. (Company Profile, Sales Data etc.)
• 4.10 Takeda Pharmaceutical Company Limited (Company Profile, Sales Data etc.)
• 4.11 Tonix Pharmaceuticals Holding Corp. (Company Profile, Sales Data etc.)
• 4.12 Verrica Pharmaceuticals Inc. (Company Profile, Sales Data etc.)

5 Market Competition

• 5.1 Company Competition
• 5.2 Regional Market by Company

6 Demand by End Market

• 6.1 Demand Situation
  • 6.1.1 Demand in Hospital
  • 6.1.2 Demand in Clinic
  • 6.1.3 Demand in Others
• 6.2 Regional Demand Comparison
• 6.3 Demand Forecast

7 Region Operation

• 7.1 Regional Production
• 7.2 Regional Market
• 7.3 by Region
  • 7.3.1 North America
    • 7.3.1.1 Overview
    • 7.3.1.2 by Country (U.S., Canada, Mexico)
  • 7.3.2 Europe
    • 7.3.2.1 Overview
    • 7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)
  • 7.3.3 Asia-Pacific
    • 7.3.3.1 Overview
    • 7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)
  • 7.3.4 South America
    • 7.3.4.1 Overview
    • 7.3.4.2 by Country (Brazil, Argentina etc.)
  • 7.3.5 Middle East & Africa
    • 7.3.5.1 Overview
    • 7.3.5.2 by Country (Saudi Arabia, South Africa etc.)
• 7.4 Regional Import & Export
• 7.5 Regional Forecast

8 Marketing & Price

• 8.1 Price and Margin
  • 8.1.1 Price Trends
  • 8.1.2 Factors of Price Change
  • 8.1.3 Manufacturers Gross Margin Analysis
• 8.2 Marketing Channel

9 Research Conclusion

List of Tables

Table Upstream Segment of Poxviridae Infections Drug

Table Application Segment of Poxviridae Infections Drug

Table Global Poxviridae Infections Drug Market 2013-2024, by Application, in USD Million

Table Major Company List of CJ-40011

Table Major Company List of 24a

Table Major Company List of BA-368

Table Major Company List of Others

Table Global Poxviridae Infections Drug Market 2013-2018, by Type, in USD Million

Table Global Poxviridae Infections Drug Market 2013-2018, by Type, in Volume

Table Global Poxviridae Infections Drug Market Forecast 2019-2024, by Type, in USD Million

Table Global Poxviridae Infections Drug Market Forecast 2019-2024, by Type, in Volume

Table Bavarian Nordic A/S Overview List

Table Poxviridae Infections Drug Business Operation of Bavarian Nordic A/S (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table BioFactura, Inc. Overview List

Table Poxviridae Infections Drug Business Operation of BioFactura, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table CEL-SCI Corporation Overview List

Table Poxviridae Infections Drug Business Operation of CEL-SCI Corporation (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Chimerix, Inc. Overview List

Table Poxviridae Infections Drug Business Operation of Chimerix, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table China Biologic Products, Inc. Overview List

Table Poxviridae Infections Drug Business Operation of China Biologic Products, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table CJ HealthCare Corp. Overview List

Table Poxviridae Infections Drug Business Operation of CJ HealthCare Corp. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table EpiVax, Inc. Overview List

Table Poxviridae Infections Drug Business Operation of EpiVax, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table N & N Pharmaceuticals Inc. Overview List

Table Poxviridae Infections Drug Business Operation of N & N Pharmaceuticals Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table SIGA Technologies, Inc. Overview List

Table Poxviridae Infections Drug Business Operation of SIGA Technologies, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Takeda Pharmaceutical Company Limited Overview List

Table Poxviridae Infections Drug Business Operation of Takeda Pharmaceutical Company Limited (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Tonix Pharmaceuticals Holding Corp. Overview List

Table Poxviridae Infections Drug Business Operation of Tonix Pharmaceuticals Holding Corp. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Verrica Pharmaceuticals Inc. Overview List

Table Poxviridae Infections Drug Business Operation of Verrica Pharmaceuticals Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Global Poxviridae Infections Drug Sales Revenue 2013-2018, by Company, in USD Million

Table Global Poxviridae Infections Drug Sales Revenue Share, by Company, in USD Million

Table Global Poxviridae Infections Drug Sales Volume 2013-2018, by Company, in Volume

Table Global Poxviridae Infections Drug Sales Volume Share 2013-2018, by Company, in Volume

Table Major Consumers List and Overview

Table Regional Demand Comparison List

Table Major Application in Different Regions

Table Poxviridae Infections Drug Demand Forecast 2019-2024, by Application, in USD Million

Table Poxviridae Infections Drug Demand Forecast 2019-2024, by Application, in Volume

Table Poxviridae Infections Drug Production 2013-2018, by Region, in USD Million

Table Poxviridae Infections Drug Production 2013-2018, by Region, in Volume

Table Global Poxviridae Infections Drug Market 2013-2018, by Region, in USD Million

Table Global Poxviridae Infections Drug Market Share 2013-2018, by Region, in USD Million

Table Global Poxviridae Infections Drug Market 2013-2018, by Region, in Volume

Table Global Poxviridae Infections Drug Market Share 2013-2018, by Region, in Volume

Table North America Poxviridae Infections Drug Market Size 2013-2018, by Country, in USD Million

Table North America Poxviridae Infections Drug Market Size 2013-2018, by Country, in Volume

Table Europe Poxviridae Infections Drug Market Size 2013-2018, by Country, in USD Million

Table Europe Poxviridae Infections Drug Market Size 2013-2018, by Country, in Volume

Table Asia-Pacific Poxviridae Infections Drug Market Size 2013-2018, by Country, in USD Million

Table Asia-Pacific Poxviridae Infections Drug Market Size 2013-2018, by Country, in Volume

Table South America Poxviridae Infections Drug Market Size 2013-2018, by Country, in USD Million

Table South America Poxviridae Infections Drug Market Size 2013-2018, by Country, in Volume

Table Middle East & Africa Poxviridae Infections Drug Market Size 2013-2018, by Country, in USD Million

Table Middle East & Africa Poxviridae Infections Drug Market Size 2013-2018, by Country, in Volume

Table Poxviridae Infections Drug Market Forecast 2019-2024, by Region, in USD Million

Table Poxviridae Infections Drug Market Forecast 2019-2024, by Region, in Volume

Table Price Factors List

List of Figures

Figure Global Poxviridae Infections Drug Market Growth 2013-2018, by Type, in USD Million

Figure Global Poxviridae Infections Drug Market Growth 2013-2018, by Type, in Volume

Figure North America Poxviridae Infections Drug Market Concentration, in 2018

Figure Europe Poxviridae Infections Drug Market Market Concentration, in 2018

Figure Asia-Pacific Poxviridae Infections Drug MMarket Concentration, in 2018

Figure South America Poxviridae Infections Drug Market Concentration, in 2018

Figure Middle East & Africa Poxviridae Infections Drug Market Concentration, in 2018

Figure Poxviridae Infections Drug Demand in Hospital, 2013-2018, in USD Million

Figure Poxviridae Infections Drug Demand in Hospital, 2013-2018, in Volume

Figure Poxviridae Infections Drug Demand in Clinic, 2013-2018, in USD Million

Figure Poxviridae Infections Drug Demand in Clinic, 2013-2018, in Volume

Figure Poxviridae Infections Drug Demand in Others, 2013-2018, in USD Million

Figure Poxviridae Infections Drug Demand in Others, 2013-2018, in Volume

Figure North America Poxviridae Infections Drug Market Size and Growth 2013-2018, in USD Million

Figure North America Poxviridae Infections Drug Market Size and Growth 2013-2018, in Volume

Figure Europe Poxviridae Infections Drug Market Size and Growth 2013-2018, in USD Million

Figure Europe Poxviridae Infections Drug Market Size and Growth 2013-2018, in Volume

Figure Asia-Pacific Poxviridae Infections Drug Market Size and Growth 2013-2018, in USD Million

Figure Asia-Pacific Poxviridae Infections Drug Market Size and Growth 2013-2018, in Volume

Figure South America Poxviridae Infections Drug Market Size and Growth 2013-2018, in USD Million

Figure South America Poxviridae Infections Drug Market Size and Growth 2013-2018, in Volume

Figure Middle East & Africa Poxviridae Infections Drug Market Size and Growth 2013-2018, in USD Million

Figure Middle East & Africa Poxviridae Infections Drug Market Size and Growth 2013-2018, in Volume

Figure Marketing Channels Overview